Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Laverock Therapeutics

Request full access

Developing a gene silencing platform for the creation of programmable, allogeneic cell therapies

Stevenage, United KingdomFounded 2021Biotech & Life Sciences

About Laverock Therapeutics

Laverock Therapeutics is pioneering a unique gene silencing platform aimed at creating advanced programmable therapies. The company's innovative technology enhances the efficacy, safety, and accessibility of cell therapies by engineering novel functionalities that respond to both intra- and extracellular cues. This approach ensures directed and responsive activities, optimizing on and off-target profiles. Laverock's solutions are versatile, applicable across various therapeutic areas and cell types. The company collaborates with leading experts and research institutes to generate supportive data and initiate pre-clinical programs. Laverock's business model focuses on leveraging its proprietary computational and screening platforms to rapidly identify preferred genetic modifications and phenotypic outputs, facilitating the development of next-generation cell therapies. Revenue is generated through partnerships, licensing agreements, and potential commercialization of its therapeutic products.

Source: Dealroom company data

At a glance

Status
Operational
Employees
36
Open positions
None listed
Dealroom signal
72.9/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, AI Drug Discovery, Techbio, Hard Tech, Techbio Drug Discovery, Digital Pharma, DT and LS, rio ai health, rio AI health life sciences
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANT✓Other financing Jun 2026 $2.9M — UK Research and Innovation ↗
GRANT✓Other financing Oct 2025 $658K — UK Research and Innovation —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Laverock Therapeutics website traffic

Latest recorded traffic for Laverock Therapeutics is 370 monthly website visits, up 270% over the last three months. Laverock Therapeutics's team declined 12.2% over the past year.

Latest monthly visits370 3-month web change+270% 1-year team growth-12.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Laverock Therapeutics in the Stevenage ecosystem

Live from Dealroom

The Laverock Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed10 investors entered at this stage

  • Calculus Capital
  • Mercia Asset Management
  • Tekfen Ventures
  • Eos Advisory
  • Maven Capital Partners
  • Future Planet Capital
  • Eli Lilly
  • Mercia Ventures
  • Norcliffe Capital
  • UK Research and Innovation

Other known investors2 additional known investors

  • Grow London
  • Kris Kemeny
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇬🇧 United Kingdom93.8%
🇺🇸 United States3.1%
🇨🇭 Switzerland3.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Laverock Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Laverock Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.